Evidence map›Paper›PMID 36912359›Full record

ArticleJournal of peptide science : an official publication of the European Peptide Society2023

Automated solid-phase synthesis of metabolically stabilized triazolo-peptidomimetics.

Xabier Guarrochena, Barbara Kaudela, Thomas L Mindt

Open access · hybridAbstract read
In one paragraph

Article in Journal of peptide science : an official publication of the European Peptide Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Automated solid-phase synthesis of metabolically stabilized triazolo-peptidomimetics.Journal of peptide science : an official publication of the European Peptide Society · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Xabier GuarrochenaDepartment of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
Barbara KaudelaDepartment of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
Thomas L MindtDepartment of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-2090-1725
University of Vienna · AT

Funding

Austrian Science Fund FWF P 31477
6 · The paper itself

Abstract

The use of 1,4-disubstituted 1,2,3-triazoles as trans-amide bond surrogates has become an important tool for the synthesis of metabolically stabilized peptidomimetics. These heterocyclic bioisosters are generally incorporated into the peptide backbone by applying a diazo-transfer reaction followed by CuAAC (click chemistry) with an α-amino alkyne. Even though the manual synthesis of backbone-modified triazolo-peptidomimetics has been reported by us and others, no procedure has yet been described for an automated synthesis using peptide synthesizers. In order to efficiently adapt these reactions to an automated setup, different conditions were explored, putting special emphasis on the required long-term stability of both the diazo-transfer reagent and the Cu(I) catalyst in solution. ISA·HCl is the reagent of choice to accomplish the diazo-transfer reaction; however, it was found instable in DMF, the most commonly used solvent for SPPS. Thus, an aqueous solution of ISA·HCl was used to prevent its degradation over time, and the composition in the final diazo-transfer reaction was adjusted to preserve suitable swelling conditions of the resins applied. The CuAAC reaction was performed without difficulties using [Cu (CH

Indexed as

PeptidomimeticsSolid-Phase Synthesis TechniquesAmidesClick ChemistryPeptidesAmidesPeptidesPeptidomimeticsautomated solid-phase peptide synthesisCuAACdiazo-transfertriazolo-peptidomimetics

Identifiers

PMID36912359
PMCPMC10909554
OpenAlexW4324017483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.